The Therapeutic Goods
Administration (TGA) is seeking
comment on its review of the low
value turnover exemption (LVT)
scheme.
The LVT arrangement allows
sponsors of entries in the Australian
Register of Therapeutic Goods to
seek an exemption from payment
of annual charges, for entries
where annual turnover was less
than, or equal to, 15 times the
annual charge for that entry.
The TGA said this was a policy and
operational review of the scheme,
the first stage of which is the
release of the consultation paper.
Questions to be considered
included whether there were other
options available to address this
policy need, the TGA said.
The consultation closes on 23 May
- for more, CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 11 Apr 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Apr 14
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.